Amicus Therapeutics, Inc. (FOLD): Price and Financial Metrics

FOLD POWR Grades

• Growth is the dimension where FOLD ranks best; there it ranks ahead of 92.52% of US stocks.
• The strongest trend for FOLD is in Momentum, which has been heading up over the past 177 days.
• FOLD ranks lowest in Sentiment; there it ranks in the 8th percentile.

FOLD Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for FOLD is 2.68 -- better than 80.68% of US stocks.
• With a one year PEG ratio of 666.84, AMICUS THERAPEUTICS INC is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 95.52% of US stocks.
• With a price/sales ratio of 9.54, AMICUS THERAPEUTICS INC has a higher such ratio than 88.75% of stocks in our set.
• If you're looking for stocks that are quantitatively similar to AMICUS THERAPEUTICS INC, a group of peers worth examining would be POWI, OLED, AIP, MIRM, and APLS.
• FOLD's SEC filings can be seen here. And to visit AMICUS THERAPEUTICS INC's official web site, go to www.amicusrx.com.

FOLD Valuation Summary

• FOLD's price/sales ratio is 9.5; this is 102.13% higher than that of the median Healthcare stock.
• Over the past 193 months, FOLD's price/sales ratio has gone NA NA.

Below are key valuation metrics over time for FOLD.

FOLD Growth Metrics

Its 2 year price growth rate is now at -42%.
• Its 4 year net cashflow from operations growth rate is now at -80.01%.
• The 5 year price growth rate now stands at 74.74%.

FOLD's revenue has moved up $41,468,000 over the prior 15 months.

The table below shows FOLD's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	323.291	-156.317	-263.98
2022-06-30	321.145	-168.391	-280.988
2022-03-31	317.827	-188.452	-270.056
2021-12-31	305.514	-202.491	-250.46
2021-09-30	293.931	-181.799	-238.584
2021-06-30	281.823	-200.107	-252.301

FOLD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• FOLD has a Quality Grade of C, ranking ahead of 63.39% of graded US stocks.
• FOLD's asset turnover comes in at 0.333 -- ranking 138th of 680 Pharmaceutical Products stocks.
• RDUS, CLVS, and NSTG are the stocks whose asset turnover ratios are most correlated with FOLD.

The table below shows FOLD's key quality metrics over time.